ARCHIVES

Crout Resigns As Director Of FDA Drugs Bureau

This article is from The Cancer Letter archive.

Vol. 06 No. 28 | July 11, 1980

Download PDF Visit The Full Archive

Related Articles

House Passes Cancer Act Renewal With Provision Permitting NCI To Reinstate Training Program

May 10, 1974

Toxicology Program Board To Review Nine Substances.

January 14, 2000

ACS Concludes That Laetrile Organization Is Insignificant

November 29, 1991

Guidelines Adopted For Pathology Review

February 22, 1980

Michael Grever To Head DTP; Chabner’s Deputy Is Kaufman; Radiation Program To Be Split

April 5, 1991

Senate Votes To Invalidate Task Force Guideline

December 4, 2009